• Search Funds
  • Model Portfolios
  • Provider
  • Sector
  • Manager

Search by provider name

Search by sector name

Search by manager name

Search by Risk Level

Hermes Impact Opportunities Equity (Restricted Fund)

  • Fund Info & charges
  • Performance
  • Fund breakdown
  • Dividend History
Fund Provider Hermes Fund Managers Ireland Ltd
Fund Summary The investment objective of the Fund is to achieve long term capital appreciation by investing in companies which will benefit from meeting the world™s environmental and social challenges.
SEDOL code BD3FNZ8
ISIN IE00BD3FNZ88
Fund code HEIOE
Managers Tim Crockford
Manager Tenure 2 years
Morningstar Category Global Large-Cap Blend Equity
IMA Sector Global
Fund Size £224 million
Fund Type OEIC
Management Style Active
Total Expense Ratio (TER) 0.4%
Cavendish ongoing charge 0.05%
FundsNetwork Service Fee 0.20%
Minimum Initial Investment £25
Minimum Top Up £25
Minimum Monthly Investment £25
Sell Price £1.1737
Buy Price £1.1737
Price Change -1.2784%
Price Date 11th October 2019
Yield Currently unavailable
Dividend Frequency Semi-Annually
ISA Eligible Yes
SIPP Eligible Yes
Inception Date 16th September 2019
Fund Status OPEN

3-year Mean Monthly Return: Currently unavailable

Annual Returns 2018
Fund Performance +5.91%
Benchmark Performance
(Global Large-Cap Blend Equity)
+4.10%
Time Period Cumulative Benchmark Performance
(Global Large-Cap Blend Equity)
Fund Compared to Benchmark
1 day -1.28% +15.00% -16.27%
1 week -1.62% -2.95% +1.33%
1 month -3.87% -2.89% -0.98%
3 months -4.13% +3.29% -7.41%
6 months 1.54% +8.81% -7.27%
1 year 15.50% +3.57% +11.93%
3 years Currently unavailable Currently unavailable Currently unavailable
5 years Currently unavailable Currently unavailable Currently unavailable
10 years Currently unavailable Currently unavailable Currently unavailable
YTD 16.48% -1.25% +17.74%
Since inception 9.28% Currently unavailable Currently unavailable

Top 10 shares for this fund

Share Name Country Value
Novo Nordisk A/S B DNK 4.72%
Bank Rakyat Indonesia (Persero) Tbk Class B IDN 4.69%
Illumina Inc USA 4.48%
Ansys Inc USA 4.18%
Orsted A/S DNK 4.18%
Xylem Inc USA 4.16%
Hannon Armstrong Sustainable Infrastructure Capital Inc USA 4.06%
Abcam PLC GBR 4.03%
Lonza Group Ltd CHE 4.01%
Emergent BioSolutions Inc USA 4.01%

Currently unavailable